FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arya Biragyn

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Immunotherapy

Disorders

Co-author Network

Publications

TOP 3
Arya Biragyn; Monica Bodogai; Sinan R Denny-Brown; Cory M Hogaboam; Shiro Kanegasaki; Purevdorj B Olkhanud; Nitin Puri; Katarzyna Wejksza; Koichi Ayukawa; Catalina Lee-Chang
Inhibition of Lung Metastasis by Chemokine CCL17-mediated In Vivo Silencing of Genes in CCR4+ Tregs.
Monica Bodogai; Andrew C Chan; Ronald E Gress; Charles Hesdorffer; Jinping Lai; Catalina Lee Chang; Maria Merino; Katarzyna Wejksza; Robert P Wersto; Arya Biragyn
Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.
Katarzyna Wejksza; Kevin Becker; Monica Bodogai; Jessica Bonzo; Frank J Gonzalez; Catalina Lee-Chang; Elin Lehrmann; Arya Biragyn
Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arya Biragyn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Arya Biragyn; Monica Bodogai; Sinan R Denny-Brown; Cory M Hogaboam; Shiro Kanegasaki; Purevdorj B Olkhanud; Nitin Puri; Katarzyna Wejksza; Koichi Ayukawa; Catalina Lee-Chang
Inhibition of Lung Metastasis by Chemokine CCL17-mediated In Vivo Silencing of Genes in CCR4+ Tregs.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2013;36(4):258-67.
2013: Monica Bodogai; Andrew C Chan; Ronald E Gress; Charles Hesdorffer; Jinping Lai; Catalina Lee Chang; Maria Merino; Katarzyna Wejksza; Robert P Wersto; Arya Biragyn
Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.
Cancer research 2013;73(7):2127-38.
2013: Katarzyna Wejksza; Kevin Becker; Monica Bodogai; Jessica Bonzo; Frank J Gonzalez; Catalina Lee-Chang; Elin Lehrmann; Arya Biragyn
Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(6):2575-84.
2013: Alberto R Cervantes-Villagrana; Antonio Enciso-Moreno; Rogelio Hernández Pando; Margarita Martínez-Fierro; Arya Biragyn; Monica Bodogai; Julio Castañeda-Delgado; Eduardo Sada; Valentin Trujillo; Bruno Rivas-Santiago
Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.
Vaccine 2013;31(4):676-84.
2012: Charles Hesdorffer; Robert T Kennedy; Dan L Longo; Omar S Mabrouk; Karen Madara; Enkhzol Malchinkhuu; Janice B Schwartz; Dennis D Taub; Arya Biragyn; Luigi Ferrucci; Edward J Goetzl
Distinctive immunoregulatory effects of adenosine on T cells of older humans.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(3):1301-10.
2012: Purevdorj B Olkhanud; Sarah Rothman; Koichi Ayukawa; Monica Bodogai; Srinivasulu Chigurupati; Neil Feldman; Jong-Hwan Lee; Enkhzol Malchinkhuu; Mark P Mattson; Mohammed Mughal; Kunio Nagashima; Eitan Okun; Arya Biragyn
DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease.
Vaccine 2012;30(9):1650-8.
2012: Arya Biragyn; Dan L Longo
Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.
Seminars in cancer biology 2012;22(1):50-9.
2012: Arya Biragyn; Catalina Lee-Chang
A new paradigm for an old story: the role of regulatory B cells in cancer.
Frontiers in immunology 2012;3():206.
2011: Purevdorj B Olkhanud; Yrina Rochman; Monica Bodogai; Enkhzol Malchinkhuu; Katarzyna Wejksza; Mai Xu; Ronald E Gress; Charles Hesdorffer; Warren J Leonard; Arya Biragyn
Thymic stromal lymphopoietin is a key mediator of breast cancer progression.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(10):5656-62.
2011: Purevdorj B Olkhanud; Bazarragchaa Damdinsuren; Monica Bodogai; Ronald E Gress; RANJAN SEN; Katarzyna Wejksza; Enkhzol Malchinkhuu; Robert P Wersto; Arya Biragyn
Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.
Cancer research 2011;71(10):3505-15.
2009: Dolgor Baatar; Purevdorj B Olkhanud; Valerie Wells; Fred E Indig; Livio Mallucci; Arya Biragyn
Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation.
Brain, behavior, and immunity 2009;23(7):1028-37.
2009: Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
Cancer research 2009;69(14):5996-6004.
2009: Giovanni Almanzar; Purevdorj B Olkhanud; Monica Bodogai; Chiara Dell'Agnola; Dolgor Baatar; Stephen M Hewitt; Claudio Ghimenton; Mohan K Tummala; Ashani T Weeraratna; Keith Hoek; Natalay Kouprina; Vladimir Larionov; Arya Biragyn
Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):1954-63.
2009: Prabakaran Ponraj; Zhongyu Zhu; Xiaodong Xiao; Arya Biragyn; Antony S Dimitrov; Christopher C Broder; Dimiter S Dimitrov
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.
Expert opinion on biological therapy 2009;9(3):355-68.
2009: Manik C Ghosh; Dolgor Baatar; Gary Collins; Arnell Carter; Fred Indig; Arya Biragyn; Dennis D Taub
Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck.
Blood 2009;113(3):575-84.
2008: Arya Biragyn; Marta Coscia; Kunio Nagashima; Michael Sanford; Howard A Young; Purevdorj Olkhanud
Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2.
Journal of leukocyte biology 2008;83(4):998-1008.
2008: Nina Movsesyan; Anahit Ghochikyan; Mkrtichyan Mikayel; Irina Petrushina; Hayk Davtyan; Purevdorj B Olkhanud; Elizabeth Head; Arya Biragyn; David H Cribbs; Michael G Agadjanyan
Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.
PloS one 2008;3(5):e2124.
2007: Dolgor Baatar; Purevdorj Olkhanud; Dianne Newton; Kenya Sumitomo; Arya Biragyn
CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1996-2004.
2007: Arya Biragyn; Roberta Schiavo; Purevdorj Olkhanud; Kenya Sumitomo; Alan King; Megan McCain; Fred E Indig; Giovanni Almanzar; Dolgor Baatar
Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(2):1381-8.
2007: Dolgor Baatar; Purevdorj Olkhanud; Kenya Sumitomo; Dennis Taub; Ronald Gress; Arya Biragyn
Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(8):4891-900.
2007: Chiara Dell'Agnola; Arya Biragyn
Clinical utilization of chemokines to combat cancer: the double-edged sword.
Expert review of vaccines 2007;6(2):267-83.
2006: Roberta Schiavo; Dolgor Baatar; Purevdorj Olkhanud; Fred E Indig; Nicholas Restifo; Dennis Taub; Arya Biragyn
Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses.
Blood 2006;107(12):4597-605.
2006: Soung-Chul Cha; Larry W Kwak; Pier Adelchi Ruffini; Hong Qin; Sattva S Neelapu; Arya Biragyn
Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera.
Journal of immunological methods 2006;312(1-2):79-93.
2005: Arya Biragyn
Rationale for dendritic cell-based vaccines for acute myeloid leukemia.
Haematologica 2005;90(8):1010C.
2005: Arya Biragyn
Defensins--non-antibiotic use for vaccine development.
Current protein & peptide science 2005;6(1):53-60.
2005: Oleg Chertov; John T Simpson; Arya Biragyn; Thomas P Conrads; Timothy D Veenstra; Robert J Fisher
Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery.
Expert review of proteomics 2005;2(1):139-45.
2004: Arya Biragyn; Pier Adelchi Ruffini; Marta Coscia; Linda K Harvey; Sattva S Neelapu; Sivasubramanian Baskar; Ji-Ming Wang; Larry W Kwak
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo.
Blood 2004;104(7):1961-9.
2004: Pier Adelchi Ruffini; Arya Biragyn; Marta Coscia; Linda K Harvey; Soung-Chul Cha; Bjarne Bogen; Larry W Kwak
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis.
Journal of leukocyte biology 2004;76(1):77-85.
2004: Marta Coscia; Arya Biragyn
Cancer immunotherapy with chemoattractant peptides.
Seminars in cancer biology 2004;14(3):209-18.
2004: Oleg Chertov; Arya Biragyn; Larry W Kwak; John T Simpson; Tatiana Boronina; Van M Hoang; DaRue A Prieto; Thomas P Conrads; Timothy D Veenstra; Robert J Fisher
Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry.
Proteomics 2004;4(4):1195-203.
2004: De Yang; Arya Biragyn; David M Hoover; Jacek Lubkowski; Joost J Oppenheim
Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.
Annual review of immunology 2004;22():181-215.
2003: Joost J Oppenheim; Arya Biragyn; Larry W Kwak; De Yang
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity.
Annals of the rheumatic diseases 2003;62 Suppl 2():ii17-21.
2002: Arya Biragyn; Pier Adelchi Ruffini; Cynthia A Leifer; Elena N Klyushnenkova; Alexander N Shakhov; Oleg Chertov; Aiko K Shirakawa; Joshua M Farber; David M Segal; Joost J Oppenheim; Larry W Kwak
Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.
Science (New York, N.Y.) 2002;298(5595):1025-9.
2002: Pier Adelchi Ruffini; Sattva S Neelapu; Larry W Kwak; Arya Biragyn
Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Haematologica 2002;87(9):989-1001.
2002: Arya Biragyn; Igor M Belyakov; Yen-Hung Chow; Dimiter S Dimitrov; Jay A Berzofsky; Larry W Kwak
DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses.
Blood 2002;100(4):1153-9.
2002: De Yang; Arya Biragyn; Larry W Kwak; Joost J Oppenheim
Mammalian defensins in immunity: more than just microbicidal.
Trends in immunology 2002;23(6):291-6.
2002: Pier Adelchi Ruffini; Arya Biragyn; Larry W Kwak
Recent advances in multiple myeloma immunotherapy.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2002;56(3):129-32.
2002: Arya Biragyn; Larry W Kwak
Models for lymphoma.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2002;Chapter 20():Unit 20.6.
2002: Joost J Oppenheim; De Yang; Arya Biragyn; O M Zack Howard; Paul H Plotz
Chemokine receptors on dendritic cells promote autoimmune reactions.
Arthritis research 2002;4 Suppl 3():S183-8.
2001: Arya Biragyn; M Surenhu; Dafeng Yang; Pier Adelchi Ruffini; B A Haines; Elena N Klyushnenkova; Joost J Oppenheim; Larry W Kwak
Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(11):6644-53.
2000: Arya Biragyn; Larry W Kwak
Designer cancer vaccines are still in fashion.
Nature medicine 2000;6(9):966-8.
1999: Arya Biragyn; Larry W Kwak
B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions.
Immunological reviews 1999;170():115-26.
1999: Arya Biragyn; K Tani; M C Grimm; S Weeks; Larry W Kwak
Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
Nature biotechnology 1999;17(3):253-8.